Honeyman Cipher settles with Unified Patents

On March 20, 2020, a joint motion to terminate pursuant to settlement was filed in IPR2020-00213 by Unified Patents and Honeyman Cipher Solutions, LLC (an NPE) regarding U.S. Patent 5,991,399. The ‘399 patent, directed to secure distribution of information using encryption, has been asserted against Snap, Groupon, and LogMeIn for uploading mobile apps for authentication and distribution.

The patent was previously asserted in 2015 and 2016 by Plano Encryption Technologies (another NPE) against banks and various other companies (State Farm, Best Buy, Etsy, Match.com, Shutterfly) before being transferred to Honeyman.

Unified was represented by in-house counsel David Seastrunk and Ashraf Fawzy in this proceeding. View Honeyman's district court litigation.  To read the petition and view the case record, see Unified's Portal. 

Synkloud Technologies patent determined to be likely unpatentable

On March 19, 2020, the Patent Trial and Appeal Board (PTAB) instituted trial on all challenged claims in an IPR filed by Unified against U.S. Patent 9,098,526, owned and asserted by Synkloud Technologies, LLC, an NPE.  The ‘526 patent, directed to providing remote storage for wireless devices, has been asserted against Hewlett-Packard and Blu Products.

Unified is represented by Duane Morris in this proceeding.  View Synkloud's district court litigation.  To read the institution decision and view the case record, see Unified's Portal.

Help stop bad Theranos patents from deterring investment in viral testing

In light of the serious public interest involved in ensuring that questionable patents are not used to extract money and resources from those deploying important diagnostics tests, we at Unified have launched special PATROLL crowdsourcing contests against Labrador Diagnostics / Fortress Investments / Softbank (Fortress) patents U.S. 8,283,155 and U.S. 10,533,994.  Rather than offer a reward, we believe it is in the best interest of the community (and the world) to widely, freely, and quickly publish the results to help eliminate invalid patents that could hinder COVID-19 diagnostics tests in these trying times. 

Fortress recently acquired the Theranos patents (listing Elizabeth Holmes as the lead inventor) and has asserted them against U.S. diagnostics companies through a newly formed NPE called Labrador Diagnostics LLC.  Shortly after they filed suit, a defendant announced it was making COVID-19 diagnostics tests for the government based on the technology at issue. In response, Fortress announced they would offer royalty-free licenses for COVID-19 testing, but they refuse to drop the suit, and are seeking to enjoin the company from making, using, or selling a wide array of diagnostics.  We believe everyone should chip in to deter such bad behavior, especially from entities like Fortress that have a long history of asserting patents often found invalid when challenged.

We kindly ask our crowdsourcing community of thousands of prior art searchers to take a few minutes to help identify prior art on these patents that never should have issued and help rid the world of them, in the process improving the world’s chances of testing for and containing COVID-19 and other dangerous public health concerns.

The contest will expire on April 30, 2020. Please visit PATROLL for more information or to submit an entry for this contest.

Federal Circuit affirms Unified IPR victory against Intellectual Ventures patent

On March 17, 2020, the U.S. Court of Appeals for the Federal Circuit issued a nonprecedential opinion in Intellectual Ventures I LLC v. Unified Patents, LLC, affirming a decision by the Patent Trial and Appeal Board in IPR2016-01643 that held several challenged claims of U.S. Patent 6,775,745 unpatentable. The '745 patent generally relates to a method of caching data on a computer, and has been asserted years prior, though the case is stayed. 

On appeal, Intellectual Ventures argued that the Board misconstrued several claim limitations of the '745 patent. The Court disagreed, finding that the Board's construction was reasonable, and affirming unpatentability.

Unified was represented by Peter Ayers in the appeal, and Finnegan in the IPR. Unified was also represented by in-house counsel Jonathan Stroud and Roshan Mansinghani in these proceedings. The opinion also affirmed an unrelated IPR filed by Dell EMC, Lenovo, and NetApp.

Targeted Radio patent challenged as likely unpatentable

On March 17, 2020, Unified filed a petition for inter partes review (IPR) against U.S. Patent 8,948,684, owned and asserted by Targeted Radio LLC, an Acacia Research Corporation affiliate and well-known NPE.  The ’684 patent, generally directed to the insertion of advertising or other content into an Internet radio stream based on the user's location, has been asserted in a district court case against Pandora.  

View Targeted Radio’s district court litigation.  To read the petition and view the case record, see Unified's Portal.  Unified is represented by in-house counsel Jessica L.A. Marks and Jung Hahm in this proceeding.